Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities:    
Net income $ 454,024 $ 408,379
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 61,062 67,109
Asset impairment charges 1,374 1,327
Net gain on sale of assets 0 (1,160)
Non-cash stock-based compensation expense 46,812 52,478
Excess tax benefit from equity awards (20,187) (13,965)
Net gain on sale of marketable securities and other investments (1,728) (2,069)
Changes in assets and liabilities:    
Decrease (increase) in accounts receivable, net (34,193) 232,347
Decrease (increase) in inventories (47,481) 671
Decrease in other assets 8,470 3,367
Increase (decrease) in accounts payable 5,121 (30,866)
Increase (decrease) in deferred system profit 15,630 (10,402)
Increase in other liabilities 41,342 30,403
Net cash provided by operating activities 530,246 737,619
Cash flows from investing activities:    
Acquisition of cost method investment (1,345) 0
Acquisition of business (18,000) 0
Capital expenditures, net (54,436) (55,663)
Proceeds from sale of assets 0 1,838
Purchase of available-for-sale securities (1,156,107) (1,283,177)
Proceeds from sale of available-for-sale securities 723,225 910,535
Proceeds from maturity of available-for-sale securities 110,924 200,853
Purchase of trading securities (53,046) (33,917)
Proceeds from sale of trading securities 53,400 34,492
Net cash used in investing activities (395,385) (225,039)
Cash flows from financing activities:    
Issuance of common stock 92,100 95,542
Tax withholding payments related to vested and released restricted stock units (51,556) (29,160)
Common stock repurchases (180,686) (204,943)
Payment of dividends to stockholders (224,405) (199,712)
Excess tax benefit from equity awards 20,187 13,965
Net cash used in financing activities (344,360) (324,308)
Effect of exchange rate changes on cash and cash equivalents 332 (5,365)
Net increase (decrease) in cash and cash equivalents (209,167) 182,907
Cash and cash equivalents at beginning of period 985,390 751,294
Cash and cash equivalents at end of period 776,223 934,201
Supplemental cash flow disclosures:    
Income taxes paid, net 76,877 87,245
Interest paid 26,436 27,119
Non-cash investing activities    
Purchase of land, property and equipment $ 4,103 $ 0